small molecule

ANDROGEL

TESTOSTERONE

Loss of exclusivityloss of exclusivity
CompanyBESINS HEALTHCARE IRELAND LTD

Drug detail

Brand nameANDROGEL
Active ingredientTESTOSTERONE
Strength25MG/2.5GM PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formGEL
RouteTRANSDERMAL
ModalitySmall molecule
FDA approvalFebruary 2000
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ANDROGEL patent cliff — loss of exclusivity — | CliffBio